VersaWrap for Flexor Tendon Injuries
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two treatments for Zone 2 flexor tendon injuries in the hand. One group will receive standard surgical repair, while the other will have a special protective wrap called VersaWrap applied over the repaired tendon. VersaWrap is already part of standard care at the University of Florida. The trial seeks adults who need surgery for a Zone 2 flexor tendon injury and do not have allergies to materials like alginate or hyaluronic acid. As an unphased trial, it offers patients the chance to contribute to medical research and potentially benefit from innovative treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the VersaWrap Tendon Protector is safe for flexor tendon injuries?
Research has shown that VersaWrap is generally safe and well-tolerated in tendon repair surgeries. The FDA has approved it for certain surgeries where the tendon isn't severely damaged, indicating its safety for these procedures.
In one study, 87% of patients who used VersaWrap after tendon repair achieved "Excellent" or "Good" recovery results. This suggests that most people healed well with few complications. Patients also reported low pain levels, with an average score of 1.3 out of 10, indicating that VersaWrap causes minimal discomfort.
These findings suggest that VersaWrap is a safe choice for tendon repair, with most patients experiencing good recovery and low pain.12345Why are researchers excited about this trial's treatments?
Unlike the standard of care for flexor tendon injuries, which typically involves traditional surgical repair techniques, VersaWrap offers a novel approach by incorporating an advanced bioresorbable wrap during the surgery. This wrap is designed to enhance healing by reducing scar tissue formation, which can improve the overall function and recovery time for the injured tendon. Researchers are excited about VersaWrap because it could potentially lead to better outcomes for patients, offering quicker and more complete recovery compared to conventional methods.
What evidence suggests that the VersaWrap Tendon Protector is effective for flexor tendon injuries?
This trial will compare the VersaWrap Tendon Protector with the standard surgical procedure for flexor tendon repair. Research has shown that the VersaWrap Tendon Protector may aid recovery from flexor tendon injuries. In one study, 87% of patients using VersaWrap achieved "Excellent" or "Good" recovery after tendon repair. Approximately 4.6 months post-surgery, patients could actively move their tendons 88.8% of the normal range and passively move them 94.3%. Their overall function returned to 87.7%. These results suggest that VersaWrap might support healing and improve movement more effectively than standard care.12467
Who Is on the Research Team?
Ellen Satteson, MD
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
Adults with a zone 2 flexor tendon injury needing surgery can join this trial. They must be able to follow up post-surgery. People allergic to certain polysaccharides, those with serious medical or psychiatric issues, pregnant or breastfeeding women, and prisoners are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Zone 2 flexor tendon repair with or without VersaWrap Tendon Protector
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations at 2 weeks, 6 weeks, and 3 months post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- Standard of Care Surgical Procedure
- VersaWrap Treatment
Trial Overview
The study is testing if using VersaWrap Tendon Protector on repaired tendons leads to better outcomes than the standard surgical procedure without it. Participants will be randomly assigned to either receive VersaWrap or not after their tendon repair surgery.
How Is the Trial Designed?
2
Treatment groups
Active Control
VersaWrap Treatment Arm- Zone 2 flexor tendon repair with the use of VersaWrap
Standard of Care Treatment Arm- Zone 2 flexor tendon repair
Standard of Care Surgical Procedure is already approved in United States, European Union for the following indications:
- Flexor tendon injuries
- Zone 2 flexor tendon injuries
- Flexor tendon injuries
- Hand injuries
- Finger injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
Published Research Related to This Trial
Citations
Evaluating the effect of VersaWrap tendon protector on ...
In our cohort, 87% of patients achieved “Excellent” or “Good” functional status after flexor tendon repair with the VersaWrap tendon protector ...
Study Details | NCT04322370 | Prospective Randomized ...
The purpose of this study is to prospectively analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups.
Evaluating the effect of VersaWrap tendon protector on ...
At a mean follow-up of 4.6 months, the mean active and passive ROM was 88.8% and 94.3%, respectively. Mean percent return of function was 87.7%.
Evaluating the Effectiveness of Commercially Available ...
Our data showed that around 42 days after flexor tendon repair, the Collagen-GAG sheet had significantly greater histological anti-adhesion properties compared ...
Plastic and Reconstructive Surgery
The purpose of this study is to prospectively analyze outcomes between patients with zone 2 flexor tendon (Z2FT) injuries following repair, randomized to two ...
VersaWrap
VersaWrap is FDA cleared for the use in procedures where there is no significant loss of tendon tissue and is currently one of the standard of care treatments ...
Outcomes of tendon repairs using VersaWrap.
The average QuickDASH score was 30.7 (n = 44, range: 0-72.5), and the average pain score on the visual analogue scale (VAS) was 1.3/10 (n = 90, range: 0-8) ( ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.